Lorazepam 1 mg
INDICATIONS AND USAGE Lorazepam tablets are indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety or anxiety associated with depressive symptoms. Anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic. The effectiveness of lorazepam in long-term use, that is, more than 4 months, has not been assessed by systematic clinical studies. The physician should periodically reassess the usefulness of the drug for the individual patient.
Watson Laboratories, Inc.
ROUND WHITE 241 1 Watson
Related Pills
Lorazepam 1 mg
Watson Laboratories, Inc.
lorazepam 0.5 mg
actavis pharma, inc.
lorazepam 1 mg
actavis pharma, inc.
Lorazepam 0.5 mg
Watson Laboratories, Inc.
Lorazepam 1 mg
Watson Laboratories, Inc.
Lorazepam 0.5 mg
Watson Laboratories, Inc.
Lorazepam 1 MG Oral Tablet
Aphena Pharma Solutions - Tennessee, LLC
Lorazepam 1 MG Oral Tablet
McKesson Packaging Services Business Unit of
Lorazepam 1 MG Oral Tablet
Aphena Pharma Solutions - Tennessee, LLC
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
HOW SUPPLIED Lorazepam Tablets, USP are available in the following dosage strengths: 0.5 mg: white to off-white, round flat-faced, beveled edge tablet, scored on one side debossed with 240 above bisect and 0.5 below bisect and debossed WATSON on the other side, supplied in bottles of 100 (NDC 0591‐0240‐01), 500 (NDC 0591‐0240‐05) and 1000 (NDC 0591‐0240‐10). 1 mg: white to off-white, round flat-faced, beveled edge tablet, scored on one side debossed with 241 above bisect and 1 below bisect and debossed WATSON on the other side, supplied in bottlesof 100 (NDC 0591‐0241‐01), 500 (NDC 0591‐0241‐05) and 1000 (NDC 0591‐0241‐10). 2 mg: white to off-white, round flat-faced, beveled edge tablet, scored on one side debossed with 242 above bisect and 2 below bisect and debossed WATSON on the other side, supplied in bottlesof 100 (NDC 0591‐0242‐01), 500 (NDC 0591‐0242‐05) and 1000 (NDC 0591‐0242‐10). Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Dispense in a tight, light-resistant container as defined in the USP. Manufactured by: Watson Pharma Private Limited Verna, Salcette Goa 403 722 INDIA Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054 USA Rev. A 2/2021
More pills like ROUND 241 1 Watson